跳至主要内容
临床试验/NCT06394947
NCT06394947已完成不适用

Fluid Challenge in Intensive Care: a Worldwide Global Inception Cohort Study: The FENICE II Study

Humanitas Clinical and Research Center2 个研究点 分布在 1 个国家目标入组 4,734 人开始时间: 2025年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
4,734
试验地点
2
主要终点
Composite of various aspects of fluid therapy

研究概览

简要总结

Fluids are considered the primary treatment for critically ill patients admitted to the intensive care unit (ICU), aiming to replace losses and or to enhance venous return, stroke volume, and consequently, cardiac output and tissue oxygen delivery. The modalities, volumes, and targets employed to titrate fluid therapy vary significantly in current clinical practice, as shown by the original FENICE study 10 years ago. FENICE studied how fluid challenges are given at the bedside. Very little is known about how this practice has changed since, how fluid administration (maintenance) is performed in general, and how the modality may impact outcomes. FENICE II is designed to explore these issues.

Objectives:

To provide a comprehensive global description of fluid administration modalities during the initial days of ICU admission and to explore any association between fluid administration characteristics and clinical outcomes.

To describe the fluid challenge administration modality and appraise the use of variables and functional hemodynamic tests to guide bolus infusion.

详细描述

Primary aim: The primary aim is to describe the modality of fluid administration during the first 5 days of ICU stay considering 1) the overall fluid balance; 2) the characteristics of the fluids given; 3) the modality of fluid administration.

Secondary aims:

  • To explore any association between fluid administration characteristics and clinical outcomes (see further)
  • To evaluate factors potentially associated with the respective proportion of the different modalities of fluid administration
  • To characterize FC administration modality in a large cohort of ICU patients.

Statistical Analysis:

Data will be described as median and interquartile range (IQR) or number and percentage. Categorical variables were compared using Fisher's exact test and continuous variables using the nonparametric Wilcoxon test, Mann-Whitney test, or Kruskal-Wallis test.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All consecutive adult (≥18 years old) patients admitted to ICU and expected to stay at least 48h.

排除标准

  • Planned admission after surgery for overnight ICU stay.
  • Refusal of consent
  • Moribund patients (i.e. expected survival < 24h)

结局指标

主要结局

Composite of various aspects of fluid therapy

时间窗: FIve days from ICU admission

Modality of fluid administration during ICU stay considering 1) the overall fluid balance; 2) the characteristics of the fluids given; 3) the modality of fluid administration

次要结局

  • ICU mortality(Up to 30 days from ICU admission)
  • In-hospital Mortality(Up to 30 days from ICU admission)
  • Alive without any organ support(between inclusion and 30 days later)
  • Organ Dysfunction - Lung(between inclusion and 30 days later)
  • Organ Dysfunction - Heart(between inclusion and 30 days later)
  • Organ Dysfunction - Renal(between inclusion and 30 days later)
  • Organ Dysfunction(between inclusion and 5 days later)
  • Organ Dysfunction - Renal(between inclusion and 5 days later)

研究者

发起方
Humanitas Clinical and Research Center
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Fluid Challenge in Intensive Care The FENICE II Study | 临床试验